$CPXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Celator Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Celator Pharmaceuticals Inc. Get notifications about new insider transactions in Celator Pharmaceuticals Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2015 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | See Remarks | Buy | M | 2.25 | 55,000 | 123,750 | 71,594 | 16.6 K to 71.6 K (+331.45 %) |
Mar 03 2015 | CPXX | Celator Pharmaceut ... | BIZZARI JEAN-PIERRE | Director | Option Exercise | A | 2.77 | 28,000 | 77,560 | 28,000 | |
Feb 27 2015 | CPXX | Celator Pharmaceut ... | Powell Fred M | Chief Financial Off ... | Option Exercise | A | 2.79 | 55,000 | 153,450 | 55,000 | |
Feb 27 2015 | CPXX | Celator Pharmaceut ... | Powell Fred M | Chief Financial Off ... | Grant | A | 0.00 | 6,758 | 0 | 17,758 | 11 K to 17.8 K (+61.44 %) |
Feb 27 2015 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | President and Head ... | Option Exercise | A | 2.79 | 80,000 | 223,200 | 80,000 | |
Feb 27 2015 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | President and Head ... | Grant | A | 0.00 | 7,639 | 0 | 18,100 | 10.5 K to 18.1 K (+73.02 %) |
Feb 27 2015 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | A | 2.79 | 175,000 | 488,250 | 175,000 | |
Feb 27 2015 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Grant | A | 0.00 | 22,593 | 0 | 35,593 | 13 K to 35.6 K (+173.79 %) |
Nov 26 2014 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Option Exercise | P | 3.58 | 121,587 | 435,281 | 850,598 | ||
Nov 21 2014 | CPXX | Celator Pharmaceut ... | Kovner Bruce | Option Exercise | P | 3.58 | 100,000 | 358,000 | 729,011 | ||
Nov 20 2014 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Director | Buy | P | 2.15 | 20,000 | 42,940 | 20,000 | 0 to 20 K |
Nov 18 2014 | CPXX | Celator Pharmaceut ... | Powell Fred M | Chief Financial Off ... | Buy | P | 2.20 | 6,000 | 13,200 | 11,000 | 5 K to 11 K (+120.00 %) |
Nov 18 2014 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Buy | P | 2.20 | 10,000 | 22,000 | 13,000 | 3 K to 13 K (+333.33 %) |
Aug 15 2014 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 2.65 | 20,600 | 54,590 | 20,600 | |
Jun 16 2014 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | A | 2.80 | 14,000 | 39,200 | 14,000 | |
Jun 16 2014 | CPXX | Celator Pharmaceut ... | Lobacki Joseph M | Director | Option Exercise | A | 2.80 | 14,000 | 39,200 | 14,000 | |
Jun 16 2014 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 2.80 | 14,000 | 39,200 | 14,000 | |
Jun 16 2014 | CPXX | Celator Pharmaceut ... | MOLLICA JOSEPH A | Director | Option Exercise | A | 2.80 | 14,000 | 39,200 | 14,000 | |
Jun 16 2014 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | A | 2.80 | 14,000 | 39,200 | 14,000 | |
Jun 13 2014 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | A | 2.80 | 14,000 | 39,200 | 14,000 | |
May 16 2014 | CPXX | Celator Pharmaceut ... | Powell Fred M | Chief Financial Off ... | Buy | P | 2.50 | 2,500 | 6,240 | 5,000 | 2.5 K to 5 K (+100.00 %) |
Feb 20 2014 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | President and Head ... | Option Exercise | A | 3.22 | 50,000 | 161,000 | 50,000 | |
Feb 20 2014 | CPXX | Celator Pharmaceut ... | Powell Fred M | Chief Financial Off ... | Option Exercise | A | 3.22 | 50,000 | 161,000 | 50,000 | |
Feb 20 2014 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | A | 3.22 | 157,000 | 505,540 | 157,000 | |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | J | 3.58 | 358 | 1,282 | 358 | |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | J | 3.58 | 314,611 | 1,126,307 | 314,611 | |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | J | 3.58 | 26,864 | 96,173 | 0 | |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | J | 3.58 | 467,358 | 1,673,142 | 0 | |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Buy | J | 0.00 | 1,277 | 0 | 1,277 | 0 to 1.3 K |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Buy | J | 0.00 | 1,123,612 | 0 | 1,123,612 | 0 to 1.1 M |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Sell | J | 0.00 | 95,945 | 0 | 0 | 95.9 K to 0 (-100.00 %) |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Sell | J | 0.00 | 1,669,138 | 0 | 0 | 1.7 M to 0 (-100.00 %) |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Option Exercise | J | 3.58 | 44,740 | 160,169 | 44,740 | ||
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Option Exercise | J | 3.58 | 314,611 | 1,126,307 | 314,611 | ||
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Option Exercise | J | 3.58 | 26,864 | 96,173 | 0 | ||
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Option Exercise | J | 3.58 | 467,358 | 1,673,142 | 0 | ||
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Buy | J | 0.00 | 159,786 | 0 | 159,786 | 0 to 159.8 K | |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Buy | J | 0.00 | 1,123,612 | 0 | 1,123,612 | 0 to 1.1 M | |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Sell | J | 0.00 | 95,945 | 0 | 0 | 95.9 K to 0 (-100.00 %) | |
Feb 12 2014 | CPXX | Celator Pharmaceut ... | Valence Life Sciences GP II LL ... | Sell | J | 0.00 | 1,669,138 | 0 | 0 | 1.7 M to 0 (-100.00 %) | |
Dec 19 2013 | CPXX | Celator Pharmaceut ... | Lobacki Joseph M | Director | Option Exercise | A | 3.47 | 28,000 | 97,160 | 28,000 | |
Dec 17 2013 | CPXX | Celator Pharmaceut ... | Powell Fred M | VP and CFO | Buy | P | 3.50 | 2,500 | 8,750 | 2,500 | 0 to 2.5 K |
Dec 17 2013 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Buy | P | 3.50 | 3,000 | 10,490 | 3,000 | 0 to 3 K |
Nov 08 2013 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | President and Head ... | Option Exercise | M | 2.81 | 2,401 | 6,747 | 0 | |
Nov 08 2013 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | President and Head ... | Buy | M | 2.81 | 2,401 | 6,747 | 10,461 | 8.1 K to 10.5 K (+29.79 %) |
Aug 27 2013 | CPXX | Celator Pharmaceut ... | Jackson Scott Thomas | Chief Executive Off ... | Option Exercise | A | 3.12 | 430,000 | 1,339,880 | 430,000 | |
Aug 07 2013 | CPXX | Celator Pharmaceut ... | VENTURES WEST CAPITAL LTD | Option Exercise | J | 3.58 | 77,811 | 278,563 | 77,811 | ||
Aug 07 2013 | CPXX | Celator Pharmaceut ... | VENTURES WEST CAPITAL LTD | Option Exercise | J | 5.21 | 27,940 | 145,632 | 69,474 | ||
Aug 07 2013 | CPXX | Celator Pharmaceut ... | VENTURES WEST CAPITAL LTD | Buy | J | 0.00 | 156,831 | 0 | 2,146,372 | 2 M to 2.1 M (+7.88 %) | |
Jul 31 2013 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | J | 3.58 | 35,737 | 127,938 | 35,737 | |
Jul 31 2013 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | J | 3.58 | 30,708 | 109,935 | 30,708 | |
Jul 31 2013 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Buy | J | 0.00 | 59,995 | 0 | 590,427 | 530.4 K to 590.4 K (+11.31 %) |
Jul 31 2013 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Buy | J | 0.00 | 49,434 | 0 | 1,287,274 | 1.2 M to 1.3 M (+3.99 %) |
Jul 31 2013 | CPXX | Celator Pharmaceut ... | QUAKER BIO VENTURES LP | 10% Owner | Option Exercise | J | 3.58 | 35,737 | 127,938 | 35,737 | |
Jul 31 2013 | CPXX | Celator Pharmaceut ... | QUAKER BIO VENTURES LP | 10% Owner | Option Exercise | J | 3.58 | 30,708 | 109,935 | 30,708 | |
Jul 31 2013 | CPXX | Celator Pharmaceut ... | QUAKER BIO VENTURES LP | 10% Owner | Buy | J | 0.00 | 59,995 | 0 | 590,427 | 530.4 K to 590.4 K (+11.31 %) |
Jul 31 2013 | CPXX | Celator Pharmaceut ... | QUAKER BIO VENTURES LP | 10% Owner | Buy | J | 0.00 | 49,434 | 0 | 1,287,274 | 1.2 M to 1.3 M (+3.99 %) |
Jul 24 2013 | CPXX | Celator Pharmaceut ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 3.12 | 28,000 | 87,248 | 28,000 | |
Jun 05 2013 | CPXX | Celator Pharmaceut ... | Kollender Richard S | Director | Option Exercise | A | 3.12 | 28,000 | 87,248 | 28,000 | |
Jun 05 2013 | CPXX | Celator Pharmaceut ... | MOLLICA JOSEPH A | Director | Option Exercise | A | 3.12 | 28,000 | 87,248 | 28,000 | |
Jun 05 2013 | CPXX | Celator Pharmaceut ... | Mayer Lawrence David | Pres&Chief Scientif ... | Option Exercise | A | 3.12 | 200,000 | 623,200 | 200,000 | |
Jun 04 2013 | CPXX | Celator Pharmaceut ... | Powell Fred M | V P & Chief Financi ... | Option Exercise | A | 3.12 | 253,000 | 788,348 | 28,000 | |
Jun 04 2013 | CPXX | Celator Pharmaceut ... | Morenstein Scott D | Director | Option Exercise | A | 3.12 | 28,000 | 87,248 | 28,000 | |
Jun 04 2013 | CPXX | Celator Pharmaceut ... | Galbraith Kenneth | Director | Option Exercise | A | 3.12 | 28,000 | 87,248 | 28,000 | |
Jun 04 2013 | CPXX | Celator Pharmaceut ... | Zisson Alex | Director | Option Exercise | A | 3.12 | 28,000 | 87,248 | 28,000 | |
Jun 04 2013 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | A | 3.12 | 28,000 | 87,248 | 28,000 | |
May 01 2013 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | J | 3.58 | 85,777 | 307,082 | 85,777 | |
May 01 2013 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | J | 5.21 | 12,906 | 67,270 | 32,091 | |
May 01 2013 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Option Exercise | J | 5.21 | 17,895 | 93,274 | 44,495 | |
May 01 2013 | CPXX | Celator Pharmaceut ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 156,749 | 0 | 2,378,924 | 2.2 M to 2.4 M (+7.05 %) |